Fletcher JW - Search Results

1

PARP1 gene variation and microglial activity on [¹¹C]PBR28 PET in older adults at risk for Alzheimer's disease.

Kim S, Nho K, Risacher SL, Inlow M, Swaminathan S, Yoder KK, Shen L, West JD, McDonald BC, Tallman EF, Hutchins GD, Fletcher JW, Farlow MR, Ghetti B, Saykin AJ. Kim S, et al. Among authors: fletcher jw. Multimodal Brain Image Anal (2013). 2013;8159:150-158. doi: 10.1007/978-3-319-02126-3_15. Multimodal Brain Image Anal (2013). 2013. PMID: 25383391 Free PMC article.

2

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography.

Risacher SL, Tallman EF, West JD, Yoder KK, Hutchins GD, Fletcher JW, Gao S, Kareken DA, Farlow MR, Apostolova LG, Saykin AJ. Risacher SL, et al. Among authors: fletcher jw. Alzheimers Dement (Amst). 2017 Sep 23;9:57-66. doi: 10.1016/j.dadm.2017.09.001. eCollection 2017. Alzheimers Dement (Amst). 2017. PMID: 29159268 Free PMC article.

3

Prostate Specific Membrane Antigen Targeted Positron Emission Tomography of Primary Prostate Cancer: Assessing Accuracy with Whole Mount Pathology.

Bahler CD, Green M, Hutchins GD, Cheng L, Magers MJ, Fletcher J, Koch MO. Bahler CD, et al. J Urol. 2020 Jan;203(1):92-99. doi: 10.1097/JU.0000000000000501. Epub 2019 Aug 20. J Urol. 2020. PMID: 31430234 Free article.

4

The impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization.

Tapp KN, Lea WB, Johnson MS, Tann M, Fletcher JW, Hutchins GD. Tapp KN, et al. Among authors: fletcher jw. J Nucl Med. 2014 Sep;55(9):1452-8. doi: 10.2967/jnumed.113.133629. Epub 2014 Jun 30. J Nucl Med. 2014. PMID: 24982437 Free article.

5

Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.

Lea WB, Tapp KN, Tann M, Hutchins GD, Fletcher JW, Johnson MS. Lea WB, et al. Among authors: fletcher jw. J Vasc Interv Radiol. 2014 Oct;25(10):1595-603. doi: 10.1016/j.jvir.2014.06.028. Epub 2014 Aug 23. J Vasc Interv Radiol. 2014. PMID: 25156647

6

Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.

Fletcher JW, Logan TF, Eitel JA, Mathias CJ, Ng Y, Lacy JL, Hutchins GD, Green MA. Fletcher JW, et al. J Nucl Med. 2015 Jan;56(1):56-62. doi: 10.2967/jnumed.114.148106. Epub 2014 Dec 18. J Nucl Med. 2015. PMID: 25525184 Free PMC article.

7

Estimation of radiation dosimetry for ⁶⁸Ga-HBED-CC (PSMA-11) in patients with suspected recurrence of prostate cancer.

Green MA, Eitel JA, Fletcher JW, Mathias CJ, Tann MA, Gardner T, Koch MO, Territo W, Polson H, Hutchins GD. Green MA, et al. Among authors: fletcher jw. Nucl Med Biol. 2017 Mar;46:32-35. doi: 10.1016/j.nucmedbio.2016.11.002. Epub 2016 Nov 4. Nucl Med Biol. 2017. PMID: 28012435 Free article.

8

[⁶⁸Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [⁶⁸Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence.

Green MA, Hutchins GD, Bahler CD, Tann M, Mathias CJ, Territo W, Sims J, Polson H, Alexoff D, Eckelman WC, Kung HF, Fletcher JW. Green MA, et al. Among authors: fletcher jw. Mol Imaging Biol. 2020 Jun;22(3):752-763. doi: 10.1007/s11307-019-01421-7. Mol Imaging Biol. 2020. PMID: 31429050 Free PMC article.

9

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Robertson KA, Nalepa G, Yang FC, Bowers DC, Ho CY, Hutchins GD, Croop JM, Vik TA, Denne SC, Parada LF, Hingtgen CM, Walsh LE, Yu M, Pradhan KR, Edwards-Brown MK, Cohen MD, Fletcher JW, Travers JB, Staser KW, Lee MW, Sherman MR, Davis CJ, Miller LC, Ingram DA, Clapp DW. Robertson KA, et al. Among authors: fletcher jw. Lancet Oncol. 2012 Dec;13(12):1218-24. doi: 10.1016/S1470-2045(12)70414-X. Epub 2012 Oct 23. Lancet Oncol. 2012. PMID: 23099009 Free PMC article. Clinical Trial.

10

Can FDG-PET be used to predict growth of stage I lung cancer?

Tann M, Sandrasegaran K, Winer-Muram HT, Jennings SG, Welling ME, Fletcher JW. Tann M, et al. Among authors: fletcher jw. Clin Radiol. 2008 Aug;63(8):856-63. doi: 10.1016/j.crad.2008.01.012. Epub 2008 Apr 14. Clin Radiol. 2008. PMID: 18625349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters